Loading...

Elaine Ku, MD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-3546
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Clinical Scientist in Nephrology Award2013  - 2014American Kidney Fund
    Young Investigator Award/Satellite Clinical Investigator2016  - 2018National Kidney Foundation

    Collapse Overview 
    Collapse Overview
    EDUCATION
    College: University of California Los Angeles, BS
    Medical School: University of California San Diego, MD
    Medicine-Pediatrics Residency: University of Southern California
    Adult and Pediatric Nephrology Fellowship: University of California San Francisco
    Other Graduate Training: University of California San Francisco, MAS


    Collapse Research 
    Collapse Research Activities and Funding
    Racial and ethnic disparities in access to kidney transplantation.
    NIH/NIDDK R01DK115629Dec 6, 2017 - Nov 30, 2021
    Role: Principal Investigator
    UCSF Pilot for Junior Investigators
    Resource allocation program UCSFMay 1, 2017 - Apr 30, 2018
    Role: Co-PI
    Weight trajectory and its association with adverse outcomes
    National Kidney Foundation Young Investigator AwardJul 1, 2016 - Nov 30, 2017
    Role: PI
    Blood pressure trends, outcomes, and interventions in adolescents and young adults at increased cardiovascular risk
    NIH K23HL131023Feb 1, 2016 - Jan 31, 2021
    Role: Principal Investigator
    Role of pre-ESRD blood pressure management on post-ESRD outcomes
    NIH F32DK098871Dec 1, 2014 - Nov 30, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ku E, Johansen KL, McCulloch CE. Time-Centered Approach to Understanding Risk Factors for the Progression of CKD. Clin J Am Soc Nephrol. 2018 Mar 30. PMID: 29602779.
      View in: PubMed
    2. Ku E, Vittinghoff E, Jacobs DR, Lewis CE, Allen NB, Bibbins-Domingo K, Shlipak M, Kramer H, Peralta CA. Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study. Am J Kidney Dis. 2018 Mar 03. PMID: 29510922.
      View in: PubMed
    3. Ku E, McCulloch CE, Warady BA, Furth SL, Grimes BA, Mitsnefes MM. Twenty-Four-Hour Ambulatory Blood Pressure versus Clinic Blood Pressure Measurements and Risk of Adverse Outcomes in Children with CKD. Clin J Am Soc Nephrol. 2018 Mar 07; 13(3):422-428. PMID: 29440119.
      View in: PubMed
    4. Winnicki E, McCulloch CE, Mitsnefes MM, Furth SL, Warady BA, Ku E. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease. JAMA Pediatr. 2018 Feb 01; 172(2):174-180. PMID: 29255845.
      View in: PubMed
    5. Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 May; 71(5):657-665. PMID: 29217305.
      View in: PubMed
    6. Ku E, Kopple JD, McCulloch CE, Warady BA, Furth SL, Mak RH, Grimes BA, Mitsnefes M. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study. Am J Kidney Dis. 2018 May; 71(5):648-656. PMID: 29132947.
      View in: PubMed
    7. Ku E, Scherzer R, Odden MC, Shlipak M, White CL, Field TS, Benavente O, Pergola PE, Peralta CA. Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial. Blood Press. 2018 Apr; 27(2):73-81. PMID: 28952798.
      View in: PubMed
    8. Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. J Am Soc Nephrol. 2017 Sep; 28(9):2794-2801. PMID: 28473636.
      View in: PubMed
    9. Ku E, McCulloch CE, Grimes BA, Johansen KL. Racial and Ethnic Disparities in Survival of Children with ESRD. J Am Soc Nephrol. 2017 May; 28(5):1584-1591. PMID: 28034898.
      View in: PubMed
    10. Ku E, Lipkowitz MS, Appel LJ, Parsa A, Gassman J, Glidden DV, Smogorzewski M, Hsu CY. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int. 2017 02; 91(2):443-450. PMID: 27927600.
      View in: PubMed
    11. Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. Diabetes Care. 2016 12; 39(12):2218-2224. PMID: 27872156.
      View in: PubMed
    12. Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, Gutiérrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT, Wyatt C, Hsu CY. BP Control and Long-Term Risk of ESRD and Mortality. J Am Soc Nephrol. 2017 Feb; 28(2):671-677. PMID: 27516235.
      View in: PubMed
    13. Ku E, Fine RN, Hsu CY, McCulloch C, Glidden DV, Grimes B, Johansen KL. Height at First RRT and Mortality in Children. Clin J Am Soc Nephrol. 2016 May 06; 11(5):832-9. PMID: 26933189; PMCID: PMC4858481 [Available on 05/06/17].
    14. Ku E, Xie D, Shlipak M, Hyre Anderson A, Chen J, Go AS, He J, Horwitz EJ, Rahman M, Ricardo AC, Sondheimer JH, Townsend RR, Hsu CY. Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol. 2016 Jul; 27(7):2196-204. PMID: 26604213; PMCID: PMC4926969 [Available on 07/01/17].
    15. Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL. Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD. J Am Soc Nephrol. 2016 Feb; 27(2):551-8. PMID: 26054540; PMCID: PMC4731123 [Available on 02/01/17].
    16. Ku E, Johansen KL, Portale AA, Grimes B, Hsu CY. State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study. BMC Nephrol. 2015 Jan 15; 16:2. PMID: 25589150; PMCID: PMC4361136.
    17. Ku E, Glidden DV, Johansen KL, Sarnak M, Tighiouart H, Grimes B, Hsu CY. Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease. Kidney Int. 2015 May; 87(5):1055-60. PMID: 25493952; PMCID: PMC4425599.
    18. Ku E, Thomas M, Ho CH, Whipple NS, Abdul-Rahman O, Megason GC, Herrington BL, Carmody JB, Charlton JR. Index of suspicion. Case 1: fever, diarrhea, jaundice, and confusion in an 18-year-old male. Case 2: severe anemia in a 6-month-old girl. Case 3: red urine in a 4-month-old boy. Pediatr Rev. 2014 Mar; 35(3):129-35. PMID: 24585816.
      View in: PubMed
    19. Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1476-81. PMID: 23929923; PMCID: PMC3805086.
    20. Ku E, Campese V. Is lipid management effective for all stages of CKD?. Blood Purif. 2013; 35(1-3):26-30. PMID: 23343543.
      View in: PubMed
    21. Ku E, Ananthapanyasut W, Campese VM. IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA. Clin Nephrol. 2012 Feb; 77(2):146-50. PMID: 22257545.
      View in: PubMed
    22. Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function? The saga continues. J Nephrol. 2011 Sep-Oct; 24(5):550-3. PMID: 21887675.
      View in: PubMed
    23. Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. Int J Hypertens. 2011 Jan 20; 2011:814354. PMID: 21331158; PMCID: PMC3034934.
    24. Ku E, Brotherton BJ, Parrish C, Zia SK, McKenna S. Visual diagnosis: vaginal mass in a 16-month-old child. Pediatr Rev. 2010 Aug; 31(8):337-40. PMID: 20679100.
      View in: PubMed
    25. Lu Y, Ku E, Campese VM. Aldosterone in the pathogenesis of chronic kidney disease and proteinuria. Curr Hypertens Rep. 2010 Aug; 12(4):303-6. PMID: 20596805.
      View in: PubMed
    26. Ku E, Campese VM. Aldosterone and hypertension in African Americans. Am J Hypertens. 2009 Dec; 22(12):1234. PMID: 19924116.
      View in: PubMed
    27. Ku E, Cheung EL, Khan A, Yu AS. Anion and osmolal gaps after alcohol intoxication. Am J Kidney Dis. 2009 Aug; 54(2):385-8. PMID: 19560850.
      View in: PubMed
    28. Ku E, Park J, Vidhun J, Campese V. The hazards of dual renin-angiotensin blockade in chronic kidney disease. Arch Intern Med. 2009 Jun 08; 169(11):1015-8. PMID: 19506167.
      View in: PubMed
    29. Ku E, Nobakht N, Campese VM. Lixivaptan: a novel vasopressin receptor antagonist. Expert Opin Investig Drugs. 2009 May; 18(5):657-62. PMID: 19379124.
      View in: PubMed
    30. Ku E, Campese VM. Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatr Nephrol. 2009 Dec; 24(12):2301-7. PMID: 19347366.
      View in: PubMed